These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 7736403)
1. Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors. Khalid H; Yasunaga A; Kishikawa M; Shibata S Cancer; 1995 May; 75(10):2571-8. PubMed ID: 7736403 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of estrogen receptor-related antigen, progesterone and estrogen receptors in human intracranial meningiomas. Khalid H Cancer; 1994 Jul; 74(2):679-85. PubMed ID: 8033047 [TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors. Tamura R; Sato M; Morimoto Y; Ohara K; Kosugi K; Oishi Y; Kuranari Y; Murase M; Yoshida K; Toda M Exp Mol Pathol; 2020 Jun; 114():104408. PubMed ID: 32088190 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of progesterone receptor and Ki-67 labeling index in astrocytic tumors. Khalid H; Shibata S; Kishikawa M; Yasunaga A; Iseki M; Hiura T Cancer; 1997 Dec; 80(11):2133-40. PubMed ID: 9392336 [TBL] [Abstract][Full Text] [Related]
5. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation. Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073 [TBL] [Abstract][Full Text] [Related]
6. Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Pietsch T; Valter MM; Wolf HK; von Deimling A; Huang HJ; Cavenee WK; Wiestler OD Acta Neuropathol; 1997 Feb; 93(2):109-17. PubMed ID: 9039457 [TBL] [Abstract][Full Text] [Related]
7. Telomerase activity and alterations in telomere length in human brain tumors. Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival. Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536 [TBL] [Abstract][Full Text] [Related]
9. Expression of VEGF and its receptor genes in intracranial schwannomas. Uesaka T; Shono T; Suzuki SO; Nakamizo A; Niiro H; Mizoguchi M; Iwaki T; Sasaki T J Neurooncol; 2007 Jul; 83(3):259-66. PubMed ID: 17570036 [TBL] [Abstract][Full Text] [Related]
10. Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors. Hara A; Hirose Y; Yoshimi N; Tanaka T; Mori H Neurol Res; 1997 Dec; 19(6):623-8. PubMed ID: 9427964 [TBL] [Abstract][Full Text] [Related]
11. Microvessel density in brain tumors. Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of estrogen receptor expression in low-grade and high-grade astrocytomas. Tavares CB; Gomes-Braga FDCS; Sousa EB; Borges US; Escórcio-Dourado CS; Silva-Sampaio JPD; Silva BBD Rev Assoc Med Bras (1992); 2018 Dec; 64(12):1129-1133. PubMed ID: 30569990 [TBL] [Abstract][Full Text] [Related]
14. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma. Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078 [TBL] [Abstract][Full Text] [Related]
15. Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas. Yamashita Y; Kumabe T; Higano S; Watanabe M; Tominaga T Neurol Res; 2009 Nov; 31(9):940-6. PubMed ID: 19138469 [TBL] [Abstract][Full Text] [Related]
16. Role of estrogen receptor-related antigen in initiating the growth of human glioma cells. Khalid MH; Shibata S; Furukawa K; Nadel A; Ammerman MD; Caputy AJ J Neurosurg; 2004 May; 100(5):923-30. PubMed ID: 15137610 [TBL] [Abstract][Full Text] [Related]
17. Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy. Zhang JG; Kruse CA; Driggers L; Hoa N; Wisoff J; Allen JC; Zagzag D; Newcomb EW; Jadus MR J Neurooncol; 2008 May; 88(1):65-76. PubMed ID: 18259692 [TBL] [Abstract][Full Text] [Related]
18. Expression of the small heat shock protein (hsp) 27 in human astrocytomas correlates with histologic grades and tumor growth fractions. Khalid H; Tsutsumi K; Yamashita H; Kishikawa M; Yasunaga A; Shibata S Cell Mol Neurobiol; 1995 Apr; 15(2):257-68. PubMed ID: 8590455 [TBL] [Abstract][Full Text] [Related]
19. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas. Fakhrjou A; Meshkini A; Shadrvan S Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors. Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]